You are here: Industry Insights > neurodegenerative diseases

News List

Lilly to Acquire Prevail Therapeutics in $1B Deal contractpharma
December 16, 2020
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.
University of Dundee and Takeda partner on tau pathology-focused drug development pharmaceutical-technology
February 21, 2019
The University of Dundee Drug Discovery Unit has announced it has entered into a drug development partnership focused on tau pathology with Japanese pharmaceutical giant Takeda.....
Alector kicks off biotech IPOs after US government shutdown pharmaphorum
February 14, 2019
The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a knock-on effect on the stock market because of cutbacks at the Securities and Exchange Commission financial regulator.
Dementia Consortium welcomes new partners to drug discovery collaboration pharmaceutical-technology
February 14, 2019
Charity industry partnership Dementia Consortium has announced that pharmaceutical companies, Johnson & Johnson Innovation....
Tool enables imaging of neural activity with near-infrared light europeanpharmaceuticalreview
January 24, 2019
NIR-GECO1 could help the development of effective treatments for pressing health conditions, including neurodegenerative diseases
AC Immune & Lilly Partner for Alzheimer's contractpharma
December 13, 2018
AC Immune SA and Eli Lilly and Company have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease
Vect-Horus Announces Agreement With Johnson & Johnson Innovation pharmafocusasia
December 12, 2018
Vect-Horus announced today the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson......
Evotec AG, Immuneering in Discovery Alliance contractpharma
November 27, 2018
Evotec AG has entered into a research collaboration with Immuneering Corp., a data-driven drug discovery provider, to discover novel small molecules for rare hereditary metabolic diseases. Financial details were not disclosed.
Could building a unique brain fingerprint predict a drug’s effectiveness? pharmaceutical
November 19, 2018
The pTIF predicts how effective it would be to target specific biological factors for controlling the evolution of the individual patient’s neurodegenerative disease. Credit: Pixabay.
Newly discovered link between the appendix and Parkinson’s disease could point to the way to treatments fiercebiotech
November 02, 2018
Scientists led by the Van Andel Research Institute in Michigan scoured two large patient registries, encompassing data from 1.7 million people, and made an astounding ...

Previous page 1 2 Next page